Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Apr 14, 2025 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Diabetes Research Institute (DRI) “Aggressively Working” on T1D Cure Microbiome Therapy To Delay T1D Onset Fully Closed AID Systems Effective Without Meal Announcements 2025 Breakthroughs in Diabetes...
Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

Jan 22, 2024 | Diabetes Business, Featured, Research News, Technology Updates

embecta Announces FDA 510(k) Submission for Insulin Patch Pump announced by Embecta, 9 January 2024. Embecta Corp., a global diabetes care company with a 100-year legacy in insulin delivery, announced that it has submitted a 510(k) premarket filing to the U.S. Food...
Savvy Updates 10/16/23: Insulet Wins Prelim Injunction v. EOFlow, T1D & Emotional Distress, Best Buy Sells CGMs, Treating CKD in T1D, Vertex New Data, Biomea Fusion’s Cell Therapy Application Cleared, 6th Basic Flavor – Umami, NPs Sue for “Dr.” Title, Avg Body Temp Lower Than 98.6

Savvy Updates 10/16/23: Insulet Wins Prelim Injunction v. EOFlow, T1D & Emotional Distress, Best Buy Sells CGMs, Treating CKD in T1D, Vertex New Data, Biomea Fusion’s Cell Therapy Application Cleared, 6th Basic Flavor – Umami, NPs Sue for “Dr.” Title, Avg Body Temp Lower Than 98.6

Oct 16, 2023 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Insulet wins preliminary injunction against EOFlow in patent suit by Susan Kelly for MedTechDive.com, 9 October 2023.  A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump. The U.S. District Court for...
Savvy Updates 12/19/22: Tandem Buys Sigi Patch Pump, Lilly Quits Deal with Ypsomed, Mallya Smart Sensor for Insulin Pens, Dexcom G7 with Jake Leach, Lilly & Sosei $37M Research Contract, Insulin-Mimicking Molecule, More on Dex G7

Savvy Updates 12/19/22: Tandem Buys Sigi Patch Pump, Lilly Quits Deal with Ypsomed, Mallya Smart Sensor for Insulin Pens, Dexcom G7 with Jake Leach, Lilly & Sosei $37M Research Contract, Insulin-Mimicking Molecule, More on Dex G7

Dec 19, 2022 | Featured, Research News, Technology Updates

Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market by Nick Paul Taylor for MedTechDive.com, 14 December 2022.   Tandem Diabetes Care agreed to acquire Switzerland-based AMF Medical to gain its insulin pump patch technology. Tandem...
Skip to content